Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)
Purpose To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO). Materials and methods From November 2005 to June 2009, foam sclerotherapy using polidocanol fo...
Gespeichert in:
| Veröffentlicht in: | European radiology 2011-01, Vol.21 (1), p.122-129 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 129 |
|---|---|
| container_issue | 1 |
| container_start_page | 122 |
| container_title | European radiology |
| container_volume | 21 |
| creator | Choi, Sun Young Won, Jong Yun Kim, Kyung Ah Lee, Do Yun Lee, Kwang-Hun |
| description | Purpose
To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO).
Materials and methods
From November 2005 to June 2009, foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by BRTO was performed in 16 patients (male/female 11:5; age range 46–84 years, median 67 years). Foam was made of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media, with a ratio of 1:2:1, respectively. The amount of polidocanol (2–24 mL; median 7 mL) depended on the volume of varices.
Results
Technical success was achieved in 15 of 16 patients (93.8%). Technical failure occurred in one patient. All patients were without pain during sclerotherapy. One patient experienced pulmonary edema after the procedure but completely recovered with medical treatment. There was no procedure-related mortality. Patients were followed by endoscopy, computed tomography, or both. Four patients were lost to follow-up. Clinical success was achieved in 10 of 11 patients (91%). Rebleeding occurred in one case during follow-up.
Conclusions
Foam sclerotherapy using polidocanol is clinically safe and effective for the treatment of gastric fundal varices during BRTO. |
| doi_str_mv | 10.1007/s00330-010-1895-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_815963085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202368861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-baa9c339dab0ab7fa28e4b201c58ba4dfd6e52e4ecb0ca600976f54389bfd70c3</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVoaLZpf0AuRfTS5qB0ZMm2dGxD8wGBQEnPRh_jrYNW2kh2IP--WjZtIZCTEHrm0cy8hJxwOOMA_dcCIAQw4MC40i0TB2TFpWgYByXfkBVooVivtTwi70q5BwDNZf-WHDXQi563zYr4i2Q2tLiAOc2_MZvtE13KFNd0m8LkkzMxBTqmTK0JIaXIknNh8ehpxjmndTYe6ZxNLI8Y01JosmGaq2ieUqRfvv-8uz19Tw5HEwp-eD6Pya-LH3fnV-zm9vL6_NsNc1J0M7PGaCeE9saCsf1oGoXSNsBdq6yRfvQdtg1KdBac6eo0fTe2UihtR9-DE8fk8967zelhwTIPm6k4DMFErK0Nire6E6DaSn56Qd6nJcfa3A5qVJV2FeJ7yOVUSsZx2OZpY_LTwGHYBTDsAxhgd68BDKLWfHwWL3aD_l_F341XoNkDpT7FNeb_P79u_QMNKJJ2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815284386</pqid></control><display><type>article</type><title>Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Choi, Sun Young ; Won, Jong Yun ; Kim, Kyung Ah ; Lee, Do Yun ; Lee, Kwang-Hun</creator><creatorcontrib>Choi, Sun Young ; Won, Jong Yun ; Kim, Kyung Ah ; Lee, Do Yun ; Lee, Kwang-Hun</creatorcontrib><description>Purpose
To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO).
Materials and methods
From November 2005 to June 2009, foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by BRTO was performed in 16 patients (male/female 11:5; age range 46–84 years, median 67 years). Foam was made of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media, with a ratio of 1:2:1, respectively. The amount of polidocanol (2–24 mL; median 7 mL) depended on the volume of varices.
Results
Technical success was achieved in 15 of 16 patients (93.8%). Technical failure occurred in one patient. All patients were without pain during sclerotherapy. One patient experienced pulmonary edema after the procedure but completely recovered with medical treatment. There was no procedure-related mortality. Patients were followed by endoscopy, computed tomography, or both. Four patients were lost to follow-up. Clinical success was achieved in 10 of 11 patients (91%). Rebleeding occurred in one case during follow-up.
Conclusions
Foam sclerotherapy using polidocanol is clinically safe and effective for the treatment of gastric fundal varices during BRTO.</description><identifier>ISSN: 0938-7994</identifier><identifier>EISSN: 1432-1084</identifier><identifier>DOI: 10.1007/s00330-010-1895-3</identifier><identifier>PMID: 20737152</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Aged ; Aged, 80 and over ; Balloon Occlusion - standards ; Diagnostic Radiology ; Esophageal and Gastric Varices - therapy ; Female ; Gastrointestinal Hemorrhage - therapy ; Humans ; Imaging ; Internal Medicine ; Interventional ; Interventional Radiology ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Neuroradiology ; Polidocanol ; Polyethylene Glycols - therapeutic use ; Radiology ; Safety ; Sclerosing Solutions - standards ; Sclerosing Solutions - therapeutic use ; Sclerotherapy - standards ; Treatment Outcome ; Ultrasound</subject><ispartof>European radiology, 2011-01, Vol.21 (1), p.122-129</ispartof><rights>European Society of Radiology 2010</rights><rights>European Society of Radiology 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-baa9c339dab0ab7fa28e4b201c58ba4dfd6e52e4ecb0ca600976f54389bfd70c3</citedby><cites>FETCH-LOGICAL-c436t-baa9c339dab0ab7fa28e4b201c58ba4dfd6e52e4ecb0ca600976f54389bfd70c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00330-010-1895-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00330-010-1895-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20737152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choi, Sun Young</creatorcontrib><creatorcontrib>Won, Jong Yun</creatorcontrib><creatorcontrib>Kim, Kyung Ah</creatorcontrib><creatorcontrib>Lee, Do Yun</creatorcontrib><creatorcontrib>Lee, Kwang-Hun</creatorcontrib><title>Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)</title><title>European radiology</title><addtitle>Eur Radiol</addtitle><addtitle>Eur Radiol</addtitle><description>Purpose
To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO).
Materials and methods
From November 2005 to June 2009, foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by BRTO was performed in 16 patients (male/female 11:5; age range 46–84 years, median 67 years). Foam was made of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media, with a ratio of 1:2:1, respectively. The amount of polidocanol (2–24 mL; median 7 mL) depended on the volume of varices.
Results
Technical success was achieved in 15 of 16 patients (93.8%). Technical failure occurred in one patient. All patients were without pain during sclerotherapy. One patient experienced pulmonary edema after the procedure but completely recovered with medical treatment. There was no procedure-related mortality. Patients were followed by endoscopy, computed tomography, or both. Four patients were lost to follow-up. Clinical success was achieved in 10 of 11 patients (91%). Rebleeding occurred in one case during follow-up.
Conclusions
Foam sclerotherapy using polidocanol is clinically safe and effective for the treatment of gastric fundal varices during BRTO.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Balloon Occlusion - standards</subject><subject>Diagnostic Radiology</subject><subject>Esophageal and Gastric Varices - therapy</subject><subject>Female</subject><subject>Gastrointestinal Hemorrhage - therapy</subject><subject>Humans</subject><subject>Imaging</subject><subject>Internal Medicine</subject><subject>Interventional</subject><subject>Interventional Radiology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neuroradiology</subject><subject>Polidocanol</subject><subject>Polyethylene Glycols - therapeutic use</subject><subject>Radiology</subject><subject>Safety</subject><subject>Sclerosing Solutions - standards</subject><subject>Sclerosing Solutions - therapeutic use</subject><subject>Sclerotherapy - standards</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><issn>0938-7994</issn><issn>1432-1084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU1r3DAQhkVoaLZpf0AuRfTS5qB0ZMm2dGxD8wGBQEnPRh_jrYNW2kh2IP--WjZtIZCTEHrm0cy8hJxwOOMA_dcCIAQw4MC40i0TB2TFpWgYByXfkBVooVivtTwi70q5BwDNZf-WHDXQi563zYr4i2Q2tLiAOc2_MZvtE13KFNd0m8LkkzMxBTqmTK0JIaXIknNh8ehpxjmndTYe6ZxNLI8Y01JosmGaq2ieUqRfvv-8uz19Tw5HEwp-eD6Pya-LH3fnV-zm9vL6_NsNc1J0M7PGaCeE9saCsf1oGoXSNsBdq6yRfvQdtg1KdBac6eo0fTe2UihtR9-DE8fk8967zelhwTIPm6k4DMFErK0Nire6E6DaSn56Qd6nJcfa3A5qVJV2FeJ7yOVUSsZx2OZpY_LTwGHYBTDsAxhgd68BDKLWfHwWL3aD_l_F341XoNkDpT7FNeb_P79u_QMNKJJ2</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Choi, Sun Young</creator><creator>Won, Jong Yun</creator><creator>Kim, Kyung Ah</creator><creator>Lee, Do Yun</creator><creator>Lee, Kwang-Hun</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)</title><author>Choi, Sun Young ; Won, Jong Yun ; Kim, Kyung Ah ; Lee, Do Yun ; Lee, Kwang-Hun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-baa9c339dab0ab7fa28e4b201c58ba4dfd6e52e4ecb0ca600976f54389bfd70c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Balloon Occlusion - standards</topic><topic>Diagnostic Radiology</topic><topic>Esophageal and Gastric Varices - therapy</topic><topic>Female</topic><topic>Gastrointestinal Hemorrhage - therapy</topic><topic>Humans</topic><topic>Imaging</topic><topic>Internal Medicine</topic><topic>Interventional</topic><topic>Interventional Radiology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neuroradiology</topic><topic>Polidocanol</topic><topic>Polyethylene Glycols - therapeutic use</topic><topic>Radiology</topic><topic>Safety</topic><topic>Sclerosing Solutions - standards</topic><topic>Sclerosing Solutions - therapeutic use</topic><topic>Sclerotherapy - standards</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choi, Sun Young</creatorcontrib><creatorcontrib>Won, Jong Yun</creatorcontrib><creatorcontrib>Kim, Kyung Ah</creatorcontrib><creatorcontrib>Lee, Do Yun</creatorcontrib><creatorcontrib>Lee, Kwang-Hun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choi, Sun Young</au><au>Won, Jong Yun</au><au>Kim, Kyung Ah</au><au>Lee, Do Yun</au><au>Lee, Kwang-Hun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)</atitle><jtitle>European radiology</jtitle><stitle>Eur Radiol</stitle><addtitle>Eur Radiol</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>21</volume><issue>1</issue><spage>122</spage><epage>129</epage><pages>122-129</pages><issn>0938-7994</issn><eissn>1432-1084</eissn><abstract>Purpose
To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO).
Materials and methods
From November 2005 to June 2009, foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by BRTO was performed in 16 patients (male/female 11:5; age range 46–84 years, median 67 years). Foam was made of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media, with a ratio of 1:2:1, respectively. The amount of polidocanol (2–24 mL; median 7 mL) depended on the volume of varices.
Results
Technical success was achieved in 15 of 16 patients (93.8%). Technical failure occurred in one patient. All patients were without pain during sclerotherapy. One patient experienced pulmonary edema after the procedure but completely recovered with medical treatment. There was no procedure-related mortality. Patients were followed by endoscopy, computed tomography, or both. Four patients were lost to follow-up. Clinical success was achieved in 10 of 11 patients (91%). Rebleeding occurred in one case during follow-up.
Conclusions
Foam sclerotherapy using polidocanol is clinically safe and effective for the treatment of gastric fundal varices during BRTO.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>20737152</pmid><doi>10.1007/s00330-010-1895-3</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0938-7994 |
| ispartof | European radiology, 2011-01, Vol.21 (1), p.122-129 |
| issn | 0938-7994 1432-1084 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_815963085 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Aged Aged, 80 and over Balloon Occlusion - standards Diagnostic Radiology Esophageal and Gastric Varices - therapy Female Gastrointestinal Hemorrhage - therapy Humans Imaging Internal Medicine Interventional Interventional Radiology Male Medicine Medicine & Public Health Middle Aged Neuroradiology Polidocanol Polyethylene Glycols - therapeutic use Radiology Safety Sclerosing Solutions - standards Sclerosing Solutions - therapeutic use Sclerotherapy - standards Treatment Outcome Ultrasound |
| title | Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Foam%20sclerotherapy%20using%20polidocanol%20for%20balloon-occluded%20retrograde%20transvenous%20obliteration%20(BRTO)&rft.jtitle=European%20radiology&rft.au=Choi,%20Sun%20Young&rft.date=2011-01-01&rft.volume=21&rft.issue=1&rft.spage=122&rft.epage=129&rft.pages=122-129&rft.issn=0938-7994&rft.eissn=1432-1084&rft_id=info:doi/10.1007/s00330-010-1895-3&rft_dat=%3Cproquest_cross%3E2202368861%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815284386&rft_id=info:pmid/20737152&rfr_iscdi=true |